Noriko Oza

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

Oncology, Hepatology, Medicine +10

A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff

Noriko Oza, Yuichiro Eguchi, Toshihiko Mizuta et al. · Journal of Gastroenterology · 2009 · 90 citations

Interdisciplinary Medical Staff, Weight Management, Fatty Liver Disease +17

Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016

Atsushi Masamune, Kazuhiro Kikuta, Shin Hamada et al. · Pancreatology · 2020 · 58 citations

Pancreatic Fluid Collection, Nationwide Epidemiological Survey, Clinical Epidemiology +8

Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation

Noriko Oza, Hiroshi Isoda, Toshiki Ono et al. · Hepatology Research · 2017 · 56 citations · Full text

Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis

Jun Itakura, Masayuki Kurosaki, Hiroko Setoyama et al. · Journal of Gastroenterology · 2021 · 55 citations

Liver Fibrosis, Hepatology, Viral Hepatitis +13